The Lancet Oncology

Displaying 1 - 1 of 1

Immunotherapies linked to specific heart complications

Immunotherapies linked to specific heart complications

Related Categories: 
adverse drug reactions cancer immunotherapy cancer checkpoint inhibitors Department of Medicine douglas johnson immunotherapy James C. Bradford Jr. Melanoma Fund Javid Moslehi NCI NIH The Lancet Oncology Vanderbilt Cardio-Oncology Vanderbilt Ingram Cancer Center